Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 904533 | ISIN: US74834L1008 | Ticker-Symbol: QDI
Tradegate
17.01.25
14:31 Uhr
147,50 Euro
+0,35
+0,24 %
Branche
Gesundheitswesen
Aktienmarkt
S&P 500
1-Jahres-Chart
QUEST DIAGNOSTICS INC Chart 1 Jahr
5-Tage-Chart
QUEST DIAGNOSTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
146,50148,0017.01.
146,75147,5517.01.
ACCESS Newswire
340 Leser
Artikel bewerten:
(2)

Quest Diagnostics: Lab Week 2024 - Deepika Kumar

Finanznachrichten News

NORTHAMPTON, MA / ACCESSWIRE / May 21, 2024 / Quest colleagues from coast-to-coast marked Lab Week 2024 with a week full of activities to celebrate our medical laboratory professionals and pathologists. As part of the celebration, we also featured highlights of the professional journeys of Quest colleagues from across the country.

---

From Lab Assistant to Associate Scientist
11 years at Quest
Southwest Region - Lewisville, Texas

Q: What did you initially want out of your career?
Deepika: Initially, I wanted to work and wanted to be independent.

Q: How has what you wanted changed over the years?
Deepika: Over the years, I realized working in cytogenetics makes me happy and keeps me motivated alongside achieving financial independence.

Q: Did you ever take any risks with taking on a new role, and were you encouraged to move into different roles, or did you move on your own?
Deepika: Yes, I did take risks with taking on a new role, as all my new roles has new learning demands, but I enjoyed every bit of it. Also, I am glad I took those risks/challenges.

Q: What tools or offerings from Quest did you utilize to help you in your career progression? (tuition reimbursement, EMPower trainings, etc.)
Deepika: EMPower training, onsite-trainings, and peoples' belief in my hard work and dedication.

Q: What advice would you give to someone who desires more from their current career?
Deepika: Keep looking for opportunities, projects- and never be afraid of taking risks. It might be hard at the beginning, but with your hard work and dedication, you can achieve whatever you are looking for.

Q: Which of our 5Cs do you connect with most, and why? (Customer First, Care, Collaboration, Continuous Improvement, Curiosity)
Deepika: I connect and believe in all the 5Cs, but if I must choose one, it will be continuous improvement. I believe if you keep looking for ideas and keep working hard, it will definitely improve your work and bring lots of confidence and contentment to your life.

Q: Is there anything else you would like to share?
Deepika: I believe my journey from a Lab Assistant to the current role of Associate Scientist is a testament to the growth and opportunities within our team. I started as a Lab Assistant, where my passion for technology and eagerness to learn quickly became evident. With guidance and with hard work, I gradually transitioned into a technical role. Their belief in my abilities and willingness to provide opportunities alongside my commitment to growth played a pivotal role in my professional development. As I embraced the challenges of a Lead Tech position, I continued to learn and contribute to various projects. The collaborative environment and mentorship I received allowed me to excel in my role. I am thrilled to have achieved the position of Associate Scientist. I am grateful to my entire team for fostering an environment that encourages learning and growth. I am proud to be part of a company that values its employees and provides avenues for advancement.

View additional multimedia and more ESG storytelling from Quest Diagnostics on 3blmedia.com.

Contact Info:
Spokesperson: Quest Diagnostics
Website: https://www.3blmedia.com/profiles/quest-diagnostics
Email: info@3blmedia.com

SOURCE: Quest Diagnostics



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.